memo Breast cancer classifi cation 3/2011 leading article 135 © Springer-VerlagTh e proportion of breast cancers detected in the very early stages (in situ and invasive breast cancers <15 mm) in daily practice has signifi cantly increased, thanks to breast screening, breast awareness and improved detection methods. Most of these tumours show less aggressive biological phenotype than their more advanced counterparts, and have an excellent long-term prognosis without applying oncological treatments. Th e identifi cation of the minority of cancers with a poor prognosis and their appropriate therapy is the real challenge. In fact, neither the fi rst-generation prognostic factors (the tumour size, the lymph node status and the histology grade), nor the usual additional parameters (the receptor status and proliferation markers) are reliable enough for the estimation of the outcome. Likewise, the conventional predictive factors such as the ER, PR and HER2 status are not suffi cient for the individualization of therapy in those cases that need oncological therapy. Th is overview points to the pressing need and the emerging elements of a potential new classifi cation system of early breast cancer including the consideration of the mammographic appearance, the extent of the disease instead of just the largest dimension of the main invasive focus and the mode of detection or the use of molecular tests.Keywords: Early breast cancer, classifi cation system, individualized therapy, predictive factor, prognostic factor.Signifi cant new achievements have been made in the fi eld of breast cancer in recent decades. Th e world-wide implementation of mammographic breast screening has shed light on the progressive and heterogeneous nature of breast cancer, and opened up a completely new era [1][2][3]. Th e proportion of breast cancers detected in the very early stages (in situ and invasive breast cancers <15 mm) in daily practice is steadily increasing, thanks to breast screening, heightened breast awareness and improved detection methods [4]. Most of these screen-detected cancers are non-palpable, need less radical therapy and have an excellent long-term outcome.Furthermore, a signifi cant proportion are being cured by surgery alone, and any other therapy would therefore comprise overtreatment in many cases. Th e identifi cation of the minority of cancers with a poor prognosis and their appropriate therapy is the real challenge. Th e diff erence in the outcome of the low-risk versus the high-risk breast cancer cases seems more striking in the very early stages than in the advanced stages. Nevertheless, the fi rst-generation prognostic factors (the tumour size, lymph node status and grade, which are obviously dependent on the stage of tumour progression) do not appropriately refl ect the diversity of this heterogeneous group [5,6]. Th us, new tools are needed for the characterization, and for the implementation of a new classifi cation system that could distinguish between the low-risk and the high-risk cases [3,7]. Th e experience t...